+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Organic Pharmaceutical Excipients Market - Global Forecast 2026-2032- Product Image
Organic Pharmaceutical Excipients Market - Global Forecast 2026-2032- Product Image
Sale

Organic Pharmaceutical Excipients Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4807793
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Organic Pharmaceutical Excipients Market is projected to reach USD 11.37 Billion in 2026. It is expected to continue growing at a CAGR of 8.79%, reaching USD 18.91 Billion by 2032.

Organic pharmaceutical excipients are carbon-based inactive ingredients that enable drug stability, manufacturability, bioavailability, patient acceptability, and controlled release across oral solid-dose, topical, parenteral, inhalation, and biologic formulations. They include cellulose derivatives, starches, sugars, polyols, povidone, organic acids, lipids, gums, and bio-based polymers used to support consistent drug product performance.

Demand is supported by the continued expansion of complex generics, biologics, pediatric and geriatric medicines, and patient-centric dosage forms. Buyers increasingly assess excipients through the U.S. FDA Inactive Ingredient Database, USP-NF, European Pharmacopoeia, ICH quality guidelines, supplier audit records, and documented GMP controls, making regulatory traceability, functionality evidence, and supply reliability core differentiators.

Transformative Shifts in the Landscape

The organic pharmaceutical excipients landscape is shifting from commodity sourcing toward performance-led, compliance-led, and sustainability-led procurement. Formulators are prioritizing multifunctional polymers, cellulose derivatives, lipid-based systems, starches, sugars, polyols, povidone, and natural or bio-based materials that can improve solubility, compression, taste masking, moisture protection, and release profiles.

Regulatory expectations are also rising. ICH Q8, Q9, and Q10 have embedded quality-by-design thinking, while global focus on elemental impurities, residual solvents, nitrosamine risk, allergen control, extractables and leachables, and supply-chain transparency is pushing manufacturers to strengthen documentation, change-control discipline, pharmacopeial alignment, and excipient risk assessment practices.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming cumulative across the organic pharmaceutical excipients value chain rather than isolated to R&D. Machine learning can screen excipient-API compatibility, predict stability risks, model dissolution behavior, and support formulation design of experiments, reducing avoidable laboratory iterations when validated with high-quality experimental and manufacturing data.

AI adoption is also improving supplier intelligence, regulatory surveillance, deviation analysis, specification review, process monitoring, and demand planning. However, use in regulated pharmaceutical environments requires GxP validation, audit trails, data integrity controls aligned with ALCOA+ principles, human oversight, cybersecurity safeguards, transparent model governance, and documented justification for decisions that affect product quality.

Key Regional Insights

Asia-Pacific is strengthening its role in organic pharmaceutical excipients through large-scale formulation manufacturing, expanding generic drug production, and investments across India, China, Japan, South Korea, Australia, and ASEAN markets. The region benefits from cost-competitive production, growing technical capabilities, and rising local pharmacopoeial harmonization, while regulated-market buyers remain attentive to supplier qualification, audit readiness, impurity control, and documentation depth.

North America remains a high-value region led by the United States and Canada, where FDA, USP, customer audit expectations, and advanced formulation pipelines support demand for well-characterized organic excipients with robust traceability. Europe is shaped by EMA expectations, Ph. Eur. standards, REACH considerations, sustainability requirements, and strong specialty formulation capacity. Latin America is advancing through generics production, public health procurement, and local manufacturing initiatives, with Brazil and Mexico acting as important demand centers. The Middle East is building demand through healthcare localization and medicine security programs, particularly in GCC economies, while Africa shows growing need for quality-assured excipients linked to medicine access, regional manufacturing development, and supply-chain strengthening.

Key Group Insights

ASEAN is gaining relevance as a formulation, packaging, and procurement diversification hub, with Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines supporting regional pharmaceutical manufacturing and supply-chain resilience. GCC markets are increasing demand for quality-assured organic pharmaceutical excipients as Saudi Arabia, the United Arab Emirates, and neighboring countries invest in healthcare localization, domestic production capability, and medicine security.

The European Union remains influential through harmonized regulatory procedures, Ph. Eur. standards, GMP expectations, and sustainability frameworks that shape excipient qualification across regulated markets. BRICS countries support broad demand through large patient populations, domestic pharmaceutical capacity, and active generic medicine production, while G7 economies continue to influence quality benchmarks, advanced drug delivery innovation, and regulatory expectations. NATO economies add emphasis on supply resilience, strategic healthcare preparedness, and secure sourcing of pharmaceutical inputs used in essential medicines.

Key Country Insights

The United States leads in high-value excipient qualification, driven by FDA oversight, the Inactive Ingredient Database, USP-NF standards, and sophisticated formulation pipelines for complex generics, biologics, and patient-centric dosage forms. Canada emphasizes regulated quality and supply reliability, while Mexico and Brazil support Latin American development through generics production, expanding healthcare demand, and regional manufacturing capacity. The United Kingdom, Germany, France, Italy, and Spain remain important for specialty formulation, compendial compliance, pharmaceutical manufacturing depth, and technical adoption of functional organic excipients across mature regulatory systems.

China and India are central to volume supply, active finished-dose manufacturing, and global procurement networks, with increasing attention to international audit readiness, quality system maturity, and documentation standards. Japan and South Korea emphasize high-quality specialty materials, advanced drug delivery, and stringent quality expectations, while Australia supports regulated market access, clinical supply, and Asia-Pacific distribution. Russia remains relevant for domestic medicine production, import substitution priorities, and localized pharmaceutical supply development, particularly where continuity of essential medicine manufacturing is a policy focus.

Actionable Recommendations for Industry Leaders

Industry vendors should prioritize supplier qualification programs that combine pharmacopeial testing, GMP evidence, change notification discipline, impurity risk review, and business-continuity planning. Dual sourcing should be balanced with equivalency studies, functionality testing, compatibility assessment, and regulatory impact review to avoid formulation variability and prevent avoidable post-approval change complexity.

Companies should invest in excipient characterization, predictive formulation tools, sustainability documentation, and lifecycle risk management. Strategic collaboration with specialty excipient producers, CDMOs, analytical laboratories, and regulatory experts can accelerate complex formulation development while supporting compliance with FDA, EMA, ICH, USP-NF, Ph. Eur., and WHO quality expectations. Companies should also strengthen digital quality systems, audit readiness, and data governance to support AI-enabled formulation and supply-chain decisions.

Research Methodology

The executive summary is based on secondary research from recognized regulatory, pharmacopeial, and industry sources, including FDA guidance and databases, USP-NF, European Pharmacopoeia references, EMA and ICH guidelines, WHO quality resources, supplier technical documentation, public pharmaceutical manufacturing disclosures, and documented excipient quality frameworks.

Insights were synthesized through market triangulation, regulatory review, application mapping, regional demand assessment, and qualitative validation of formulation trends. Emphasis was placed on verifiable information, documented quality requirements, pharmacopeial alignment, and commercially relevant indicators rather than unverified projections, market sizing, market share, or forecasting.

Conclusion

The organic pharmaceutical excipients market is advancing as drug developers demand materials that improve performance, support complex dosage forms, and withstand rigorous regulatory scrutiny. Progress is shaped by quality-by-design adoption, supply-chain resilience, sustainability expectations, regional manufacturing expansion, and the increasing use of data-driven formulation science.

Organizations that combine strong compliance systems, functional excipient expertise, regional supply agility, validated digital tools, and transparent documentation will be best positioned to create value in both mature regulated markets and emerging pharmaceutical economies focused on medicine access and local manufacturing capability.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Organic Pharmaceutical Excipients Market, by Product Type
7.1. Introduction
7.2. Cellulose Derivatives
7.2.1. Hydroxypropyl Methylcellulose
7.2.2. Microcrystalline Cellulose
7.3. Gelatin
7.4. Inorganic Salts
7.4.1. Calcium Phosphate
7.4.2. Magnesium Stearate
7.5. Starches And Dextrins
7.5.1. Corn Starch
7.5.2. Potato Starch
7.6. Sugars And Polymers
7.6.1. Lactose
7.6.2. Mannitol
7.6.3. Sucrose
8. Organic Pharmaceutical Excipients Market, by Form
8.1. Introduction
8.2. Gel
8.3. Granule
8.4. Liquid
8.5. Powder
9. Organic Pharmaceutical Excipients Market, by Source
9.1. Introduction
9.2. Natural
9.3. Semi Synthetic
9.4. Synthetic
10. Organic Pharmaceutical Excipients Market, by Excipient Technology
10.1. Introduction
10.2. Conventional Excipients
10.3. Co-Processed Excipients
10.4. Multifunctional Excipients
10.5. Novel Excipients
11. Organic Pharmaceutical Excipients Market, by Application
11.1. Introduction
11.2. Injectable
11.3. Ophthalmic
11.4. Oral Solid Dosage
11.4.1. Capsules
11.4.2. Tablets
11.5. Topical
12. Organic Pharmaceutical Excipients Market, by End User
12.1. Introduction
12.2. Branded Pharmaceutical Manufacturers
12.3. Generic Drug Manufacturers
12.4. Biopharmaceutical Companies
12.5. Contract Development And Manufacturing Organizations
12.6. Compounding Pharmacies
13. Organic Pharmaceutical Excipients Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Authorized Distributors
13.4. E-Procurement Platforms
14. Organic Pharmaceutical Excipients Market, by Region
14.1. Asia-Pacific
14.2. Europe
14.3. North America
14.4. Latin America
14.5. Africa
14.6. Middle East
15. Organic Pharmaceutical Excipients Market, by Group
15.1. NATO
15.2. G7
15.3. BRICS
15.4. European Union
15.5. ASEAN
15.6. GCC
16. Organic Pharmaceutical Excipients Market, by Country
16.1. China
16.2. United States
16.3. Japan
16.4. India
16.5. Germany
16.6. United Kingdom
16.7. Australia
16.8. France
16.9. South Korea
16.10. Italy
16.11. Canada
16.12. Russia
16.13. Brazil
16.14. Mexico
16.15. Spain
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Accent Microcell Limited
18.2. Archer Daniels Midland Company
18.3. Ashland Global Holdings Inc.
18.4. Associated British Foods plc
18.5. Azelis Group NV
18.6. BASF SE
18.7. Cargill Incorporated
18.8. Croda International Plc
18.9. DFE Pharma International Ltd.
18.10. Dow Inc.
18.11. DuPont de Nemours Inc.
18.12. Evonik Industries AG
18.13. Gangwal Healthcare Pvt. Ltd.
18.14. Gattefossé SAS
18.15. IMCD N.V.
18.16. Ingredion Incorporated
18.17. Innophos Holdings, Inc.
18.18. International Flavors & Fragrances Inc.
18.19. JRS Pharma GmbH & Co. KG
18.20. Kerry Group Plc
18.21. Maple Biotech Pvt. Ltd.
18.22. MEGGLE GmbH & Co. KG
18.23. Merck KGaA
18.24. Roquette Frères S.A.
18.25. Seppic SA
18.26. Shin-Etsu Chemical Co., Ltd.
18.27. Sigachi Industries Limited
18.28. SPI Pharma, Inc.
18.29. The Lubrizol Corporation
18.30. Wacker Chemie AG
List of Figures
FIGURE 1. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CELLULOSE DERIVATIVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CELLULOSE DERIVATIVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CELLULOSE DERIVATIVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL HYDROXYPROPYL METHYLCELLULOSE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL HYDROXYPROPYL METHYLCELLULOSE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL HYDROXYPROPYL METHYLCELLULOSE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MICROCRYSTALLINE CELLULOSE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MICROCRYSTALLINE CELLULOSE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MICROCRYSTALLINE CELLULOSE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL GELATIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL GELATIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL GELATIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INORGANIC SALTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL INORGANIC SALTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL INORGANIC SALTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MAGNESIUM STEARATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MAGNESIUM STEARATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MAGNESIUM STEARATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL STARCHES AND DEXTRINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL STARCHES AND DEXTRINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL STARCHES AND DEXTRINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CORN STARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CORN STARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CORN STARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL POTATO STARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL POTATO STARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL POTATO STARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SUGARS AND POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SUGARS AND POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SUGARS AND POLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL LACTOSE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL LACTOSE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL LACTOSE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL MANNITOL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL MANNITOL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL MANNITOL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SUCROSE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL SUCROSE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL SUCROSE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL GEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL GEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL GEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL GRANULE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL GRANULE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL GRANULE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL LIQUID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL POWDER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL POWDER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL POWDER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL NATURAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL NATURAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL NATURAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SEMI SYNTHETIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SEMI SYNTHETIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL SEMI SYNTHETIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL SYNTHETIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL SYNTHETIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SYNTHETIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CONVENTIONAL EXCIPIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CONVENTIONAL EXCIPIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CONVENTIONAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CO-PROCESSED EXCIPIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CO-PROCESSED EXCIPIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CO-PROCESSED EXCIPIENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL MULTIFUNCTIONAL EXCIPIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL MULTIFUNCTIONAL EXCIPIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL MULTIFUNCTIONAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL NOVEL EXCIPIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL NOVEL EXCIPIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL NOVEL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL OPHTHALMIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL OPHTHALMIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL OPHTHALMIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ORAL SOLID DOSAGE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ORAL SOLID DOSAGE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ORAL SOLID DOSAGE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CAPSULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL CAPSULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL CAPSULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL TABLETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL BRANDED PHARMACEUTICAL MANUFACTURERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL BRANDED PHARMACEUTICAL MANUFACTURERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL BRANDED PHARMACEUTICAL MANUFACTURERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL GENERIC DRUG MANUFACTURERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL GENERIC DRUG MANUFACTURERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL GENERIC DRUG MANUFACTURERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL COMPOUNDING PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL COMPOUNDING PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL COMPOUNDING PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL AUTHORIZED DISTRIBUTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL AUTHORIZED DISTRIBUTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL AUTHORIZED DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL E-PROCUREMENT PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL E-PROCUREMENT PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL E-PROCUREMENT PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 141. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 143. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 144. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 145. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 146. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 147. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 148. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 149. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 150. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 151. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 152. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 154. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 156. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 167. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 168. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 169. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 170. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 171. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 180. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 181. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 182. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 183. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 184. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 185. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 186. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 187. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 188. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 189. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 190. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 191. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 192. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 206. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 207. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 208. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 209. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 210. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 211. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 212. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 213. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 214. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 215. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 216. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 217. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 218. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 219. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 220. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 221. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 222. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 223. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 224. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 225. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 226. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 227. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 228. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 229. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 231. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 232. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 233. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 234. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 235. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 236. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 237. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 238. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 239. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 240. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 241. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 242. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 243. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 244. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 259. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 260. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 261. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 262. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 263. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 264. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 265. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 266. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 267. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 268. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 269. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 270. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 272. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 273. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 275. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 276. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 277. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 278. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 279. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 280. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 281. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 282. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 283. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 285. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 286. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 287. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 288. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 289. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 290. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 291. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 292. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 293. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 294. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 296. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 297. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 299. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 301. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 302. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 303. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 304. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 305. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 306. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 307. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 308. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 310. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 312. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 313. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 314. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 315. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 316. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 317. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2017-2032 (USD MILLION)
TABLE 318. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 319. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 320. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EXCIPIENT TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 321. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2017-2032 (USD MILLION)
TABLE 323. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 324. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 325. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 326. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 327. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2017-2032 (USD MILLION)
TABLE 328. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2017-2032 (USD MILLION)
TABLE 329. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2017-2032 (USD MILLION)
TABLE 330. INDIA ORGANIC PHARMACEUT

Companies Mentioned

  • Accent Microcell Limited
  • Archer Daniels Midland Company
  • Ashland Global Holdings Inc.
  • Associated British Foods plc
  • Azelis Group NV
  • BASF SE
  • Cargill Incorporated
  • Croda International Plc
  • DFE Pharma International Ltd.
  • Dow Inc.
  • DuPont de Nemours Inc.
  • Evonik Industries AG
  • Gangwal Healthcare Pvt. Ltd.
  • Gattefossé SAS
  • IMCD N.V.
  • Ingredion Incorporated
  • Innophos Holdings, Inc.
  • International Flavors & Fragrances Inc.
  • JRS Pharma GmbH & Co. KG
  • Kerry Group Plc
  • Maple Biotech Pvt. Ltd.
  • MEGGLE GmbH & Co. KG
  • Merck KGaA
  • Roquette Frères S.A.
  • Seppic SA
  • Shin-Etsu Chemical Co., Ltd.
  • Sigachi Industries Limited
  • SPI Pharma, Inc.
  • The Lubrizol Corporation
  • Wacker Chemie AG

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.37 Billion
Forecasted Market Value ( USD ) by 2032 $ 18.91 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Pharmaceutical Excipient Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Excipient Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Nutraceutical Excipients Market - Global Forecast 2026-2032 - Product Image

Nutraceutical Excipients Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Pharmaceutical Excipients - Global Strategic Business Report - Product Image

Pharmaceutical Excipients - Global Strategic Business Report

  • Report
  • 223 Pages
  • Global
From
Organic Pharmaceutical Excipients Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Organic Pharmaceutical Excipients Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Organic Pharmaceutical Excipients Market Report 2026 - Product Image

Organic Pharmaceutical Excipients Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Organic Pharmaceutical Excipient Market

Organic Pharmaceutical Excipients are substances used in the production of pharmaceuticals to provide stability, improve bioavailability, and enhance the delivery of active ingredients. They are used in the manufacture of tablets, capsules, and other dosage forms. Excipients are also used to improve the taste, texture, and appearance of pharmaceuticals. They are typically derived from natural sources such as plants, animals, and minerals. Organic Pharmaceutical Excipients are an important part of the Pharmaceutical Intermediates market. They are used to improve the quality and safety of pharmaceuticals, and to ensure that they meet regulatory requirements. Excipients are also used to improve the shelf life of pharmaceuticals, and to reduce the cost of production. Some companies in the Organic Pharmaceutical Excipient market include BASF, Roquette, Ashland, Croda, and Lubrizol. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.